Latest filing published 04 Feb 2026 for Onesource Specialty Pharma Limited, €2.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +50.0%Entry ₹1,162.10 · Close at T+90 ₹1,743.50
- +49.1%Entry ₹1,177.60 · Close at T+90 ₹1,756.20
- +58.2%Entry ₹1,114.00 · Close at T+90 ₹1,762.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Tenshi Pharmaceuticals Private Limited: trading record in brief
Tenshi Pharmaceuticals Private Limited appears in our data through filings on Onesource Specialty Pharma Limited shares, published by SEBI (PIT + SAST). In total, 5 filings cover trades dated from 31 January 2025 to 4 February 2026.
In open-market terms, that means 4 purchases worth €3.3M on one side and 1 sale worth €56.1M on the other. Sales outweigh purchases by €52.9M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 4 purchases and no sales on the market.
A typical purchase (the median) is worth €491k. Of 4 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster. After 4 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +50.0%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 4 February 2026: an open-market purchase of €2.2M, in Onesource Specialty Pharma Limited. Between a trade and the moment it shows up on SEBI (PIT + SAST), the median delay is 2 days. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Tenshi Pharmaceuticals Private Limited
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 205,000 shares@ ₹1,164.758795.8% of flowEquity SharesSEBI:fb96ad479327a6e978cb91c331cfc366948e3bf0Canonical exit: 3 May 2026 (T+90)
- 85,000 shares@ ₹120.09554.2% of flowEquity SharesSEBI:b29e388d9c6d9758f87d2537fde801a404bb6109Canonical exit: 5 May 2026 (T+90)
- 75,000 shares@ ₹1,161.781.4% of flowEquity SharesSEBI:396d4354bf9e11a33a96ee400edbfb26b84c384bCanonical exit: 30 Apr 2026 (T+90)
- 200,000 shares@ ₹103.89510.3% of flowEquity SharesSEBI:0ab9c589b3cff9461eada1f51678d286ca725704Canonical exit: 28 Apr 2026 (T+90)
- 3,300,970 shares@ ₹1,531.74498.3% of flowEquity SharesSEBI:fa7010af8e58338684703e4eba76752836edeff2
5 of 5 declarations